Loading
Survey (Provider) / OpenEvidence CareConnect / Survey (Participant) · Interventional Study
ClinicalTrials.gov · August 6, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a registry record for a planned interventional study evaluating safety, accuracy, and clinical impact of a generative AI patient education tool in breast cancer care at UCSF. No outcome results have been posted; the study is currently recruiting. The evidence base is therefore absent.
Interventional, Randomized, Crossover, Open label, Health Services Research purpose. Breast Cancer, Metastatic Breast Cancer, Carcinoma of the Breast; age from 18 Years. Intervention: Safety Lead-in Phase; Interventional (Immediate Access); Control (Delayed Access). n = 35. 1 site: United States.
This is a registry record for a planned interventional study evaluating safety, accuracy, and clinical impact of a generative AI patient education tool in breast cancer care at UCSF. No outcome results have been posted; the study is currently recruiting. The evidence base is therefore absent.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is an active registry record describing a planned interventional study with no results posted; outcome data are not yet available.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07512271). This is a study registration, not published results. Lead sponsor: University of California, San Francisco. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 35 participants (ESTIMATED). Conditions: Breast Cancer, Metastatic Breast Cancer, Carcinoma of the Breast. Interventions: OTHER: Survey (Participant); OTHER: OpenEvidence CareConnect; OTHER: Survey (Provider). Primary outcome measures: Mean score of Safety and Risk Assessment (Lead-in and Provider) , Up to 90 months; Mean score of Provider Assessment of AI patient Education Tool Survey (Provider) , Up to 180 days; Mean score of Assessment of Answer Accuracy and Content Appropriateness (Provider) , Uup to 180 days. Brief summary: This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.